Portfolio

Peptimmune recently completed Phase I trials of a therapy for Multiple Sclerosis. In the wake of this success, Peptimmune needed to completely overhaul its web site with updated content and present a more current and contemporary image.

iMarc and Peptimmune engaged in a rapid development process to create the new site. We rearchitected the web site's presentation of information and its content, totally redesigned the visual presentation, and implemented content management tools to enable Peptimmune's staff to keep it up to date without special software or technical knowledge.